ClinConnect ClinConnect Logo
Search / Trial NCT06150326

Medical Honey for Wound Treatment in Intensive Care. (MICARéa) Randomized, Controlled, Single-center Pilot Study.

Launched by UNIVERSITY HOSPITAL, ANGERS · Nov 20, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Honey

ClinConnect Summary

This clinical trial, called MICARéa, is investigating the use of medical honey for treating wounds in patients in the intensive care unit (ICU). Researchers want to see if honey can help wounds heal better and reduce pain compared to traditional wound care methods. Patients eligible for this study are those in the surgical ICU at CHU Angers who have at least one wound that is at least 4 cm² and has been present for less than 8 days. They also need to give consent for their participation, either themselves or through a family member.

If you or a loved one participates in this trial, you will receive either honey treatment (Activon®) or standard wound care, and the doctors will check how much your wound improves after 15 days. This study is important because it aims to find a simpler and possibly more effective option for managing wounds in critically ill patients, who often face challenges in wound healing. Please note that some individuals, such as those with certain allergies or severe health conditions, may not be eligible for this trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Hospitalization in surgical intensive care unit A -USC PTO CHU ANGERS
  • Informed consent signed by patient or relative (or emergency inclusion procedure)
  • Patient with one or more wounds ≥ 4 cm2, evolving for less than 8 days, including: stage 2, 3, 4 pressure sores, lacerations, ulcers, dermabrasions and scar disunions.
  • Exclusion Criteria:
  • Patients with honey intolerance/allergy to bee stings
  • Patients with wounds lasting more than 8 days
  • Patient with a bleeding wound,
  • Patient with a tunneled wound
  • Patients with chronic dermatoses
  • Patient with an estimated life expectancy \< 15 days
  • Expected discharge ≤48 hours.
  • No affiliation to a French social security scheme or beneficiary of such a scheme.
  • Pregnant, breast-feeding or parturient woman
  • Person deprived of liberty by judicial or administrative decision
  • Person subject to a legal protection measure

About University Hospital, Angers

The University Hospital of Angers is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to investigate new therapeutic approaches and improve patient outcomes. Committed to excellence in patient care and medical education, the University Hospital of Angers collaborates with a network of researchers and healthcare professionals to facilitate groundbreaking studies across various medical fields, ensuring rigorous adherence to ethical standards and regulatory compliance. Through its clinical trial initiatives, the institution aims to contribute significantly to the advancement of medical knowledge and the development of effective treatments.

Locations

Angers, , France

Patients applied

0 patients applied

Trial Officials

Sigismond LASOCKI, MD, PhD

Study Chair

anethesia and critical care department, CHU Angers

catherine ROD

Principal Investigator

anethesia and critical care department, CHU Angers

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported